rescuing the EFS cycle and present evidence, using EFS patients as their own controls, which confirms that EFS is a 1 To whom correspondence should be addressed drug-related problem rather than a clinical dysfunction (ZegersWe report a novel method of rescuing empty follicle Hochschild et al., 1995) . syndrome (EFS) and provide evidence that it is a drugrelated problem rather than a clinical dysfunction. In a Materials and methods preliminary study we established that in EFS the serum β-This study involved three women undergoing assisted reproductive
human chorionic gonadotrophin (β-HCG) concentrations technology (ART) at Nottingham University Research and Treatment

h after HCG administration never exceeded 10 mIU/
Unit in Reproduction (NURTURE). In all cases controlled ovarian ml. β-HCG concentrations were thus used to confirm EFS hyperstimulation was with gonadotrophin-releasing hormone agonist when oocytes were not retrieved from one ovary after (GnRHa) , buserelin, 500 mg s.c., daily (Suprefact; Hoechst UK Ltd, controlled ovarian hyperstimulation. The procedure was Hounslow, Middlesex, UK), starting in the mid-luteal phase of the suspended leaving intact all follicles in the second ovary. (ICSI) resulting in the transfer of three top grade (grade In a previous study of EFS cycles (Ndukwe et al., 1996) , we described 1) embryos. In the second case all seven mature oocytes a serum β-HCG value of Ͻ10 mIU/ml as predictive (100% predictive fertilized after in-vitro fertilization (IVF) and three grade value) of EFS. Therefore, in all three cases when no oocytes were 1 embryos were transferred resulting in a twin pregnancy, retrieved from any of the follicles in one ovary despite repeated now delivered. In the third case, five out of nine oocytes aspiration and flushing, blood was taken for urgent serum β-HCG were fertilized after ICSI and one out of the three treated estimation. If the value was Ͻ10 mIU/ml, EFS was confirmed and with high insemination concentration IVF fertilized, the procedure was suspended without aspiration of the follicles in resulting in the transfer of three ICSI embryos. not retrieved from follicles after controlled ovarian hyperstimulation, despite repeated aspiration and flushing. This is known Results as the empty follicle syndrome (EFS). It cannot be predicted by the pattern of ovarian response to stimulation either sonoNo suggestion of EFS was found during the monitoring of controlled ovarian stimulation (COH) in any of the three women graphically or hormonally (Ben Shlomo et al., 1991) . It has been described as a clinical syndrome and a cause of infertility studied, as ovarian response to stimulation was adequate sonographically and hormonally (Table I ). Prior to the first (Coulam et al., 1986; Ashkenazi et al., 1987; Galache Vega et al., 1989) . It has also been suggested that it may reflect HCG administration, β-HCG was not detectable in the serum. Thirty-six hours after HCG administration, when oocytes were dysfunctional ovulation induction (Tsuiki et al., 1988) . Despite the recognized occurrence of EFS over the years, a full not retrieved from any of the follicles on one ovary, serum β-G.Ndukwe et al. HCG was below 10 mIU/ml in every case, confirming EFS Careful and detailed investigation in all three cases confirmed that the HCG doses administered had not expired and were (Table I) . After the second administration of HCG serum, β-obtained from reliable sources. Drug storage was strictly HCG concentrations in the three subjects rose accordingly to according to the manufacturer's advice and appropriate i.m. expected values (Table II) . During the second oocyte retrieval, administration was performed without any difficulty, by a oocytes were recovered from all six follicles left intact in case trained nurse. 1, seven out of the nine follicles in case 2 and 12 out of the The problem of EFS is that of very low, inadequate bioavail-15 follicles left intact in case 3. In case 1, four out of the five ability of HCG when used as a surrogate for the luteinizing oocytes were mature (metaphase II) and all four achieved hormone (LH) surge. Because of the inconsistency of the normal fertilization [two pronuclei (2PN)] after ICSI, leading spontaneous LH surge in controlled ovarian stimulation, HCG to transfer of three grade 1 embryos; however, pregnancy was has been adopted uniformly by all successful assisted repronot achieved. In case 2, all seven oocytes were mature ductive technology programmes to effect the final triggering (metaphase II) and all fertilized normally (2PN) after in-vitro of ovulation. When pre-ovulatory follicles are present, adminisfertilization (IVF). Three grade 1 embryos were transferred, tration of HCG is followed by granulosa cell luteinization, the resulting in a twin pregnancy, now delivered. In case 3, all 12 switch from oestradiol to progesterone synthesis, resumption oocytes retrieved were mature (metaphase II); nine oocytes of meiosis and oocyte maturation and general preparation of underwent ICSI and three high insemination concentration the follicle for oocyte extrusion culminating in follicular IVF (IVF-HIC), resulting in five ICSI embryos (2PN) and one rupture after 36-40 h. The threshold duration of LH (HCG) IVF embryo (2PN).
surge concentrations required to re-initiate meiosis seems to Three grade 1 embryos were transferred but pregnancy did be 14-18 h (Seibel et al., 1982; Itskoitz-Eldor et al., 1993 ) not occur. In all subjects studied, detailed enquiry confirmed whereas metaphase II oocytes are obtainable 28 h after the appropriate storage, timing, administration and non-expiry onset of the LH (HCG) surge. dates of the HCG given.
The threshold amplitude of the LH (HCG) surge is not known for certain, but our data show that a serum β-HCG Discussion concentration Ͻ10 mIU/ml prevents pre-ovulatory changes Our data are in agreement with the observations of Ben Shlomo within the follicle. In our previous work (Ndukwe et al., 1996 (Ndukwe et al., ) et al. (1991 that EFS cannot be predicted by the pattern of the lowest concentration of serum β-HCG when oocytes were ovarian response to stimulation. Previous work by ourselves successfully retrieved following controlled ovarian stimulation (Ndukwe et al., 1996) and Zegers-Hochschild et al. (1995) was 106 mIU/ml. These data are similar to the lowest concentrashowed that EFS is consistently characterized by very low tion of 110 mIU/ml reported by Zegers-Hochschild et al. serum β-HCG concentrations after HCG administration i.m.
(1995). The concentrations of β-HCG in the serum were Ͻ10 mIU/ Studies in rats have shown that only 5% of normal LH ml in all cases of EFS encountered by our group. This was (HCG) surge amplitude is necessary for oocyte maturation, while ജ85% is needed to activate actual ovulation (Peluso the basis of the test we proposed for the prediction of EFS.
'Curing' empty follicle syndrome et al., 1990) . Similar data in humans are not available, but if second HCG from a different batch. As far as we know, this is the first description of a successful rescue of EFS cycles, these percentages are applied to our data, the minimum β-HCG concentrations necessary for oocyte maturation would and provides direct evidence, using EFS patients as their own controls, that EFS is a problem with the drug administered be~5 mIU/ml and that needed to activate actual ovulatioñ 90 mIU/ml. The projected HCG concentration for oocyte rather than a problem with the patient. An attractive proposition would be to measure routinely maturation of 5 mIU/ml is close to the 10 mIU/ml below which no oocytes were retrieved. It is therefore not surprising serum concentrations of β-HCG 12 h post-HCG administration for the timely prediction and rescue of EFS cycles in assisted that the crucial factor in the pathogenesis of EFS is the inappropriately low bioavailability of HCG.
reproductive technology. Although this seems to be a simple way of predicting EFS before attempting oocyte retrieval, it The cause of the low bioavailability after HCG administration is unclear. Postulates include: a problem with the drug is debatable whether this will be cost effective given the low incidence of this condition. The alternative would be to follow itself, its administration or a very rapid metabolic clearance of the drug by the liver. The possibility of a problem with our protocol in this report, i.e. an urgent check of serum β-HCG if no oocytes are retrieved from the follicles in one drug administration was excluded, because in all our cases, it was confirmed after careful investigation that the HCG was ovary despite aspiration and several flushes, and then to administer HCG from a totally different batch if EFS is administered correctly and at the relevant time.
The appropriate rise in serum β-HCG following the adminisconfirmed, followed by retrieval of the oocytes 36 h later. tration of HCG from a different batch rules out an intrinsic liver problem as the cause of EFS, as the second dose of HCG
